Stock buyback momentum is not slowing down! YIDU TECH (02158) spent over 11 million Hong Kong dollars on March 16 to solidify the value base of high inventory stocks.

On March 16, YIDU TECH (02158) continued to increase its share buyback, spending over HK$11 million on that day, maintaining a high-density and large-scale buyback rhythm in recent days. With a firm capital action, management once again demonstrated a high recognition of the company's intrinsic value and sufficient confidence in the long-term development of the AI medical track. As of now, the company's buyback actions since 2026 have been consistent and remarkable, with the number of buybacks steadily increasing this year. The cumulative expenditure has exceeded HK$210 million, with the proportion of treasury shares approaching 4.5%, continuously breaking the historical peak of the company. Following in the footsteps of long-term giants like AIA, very few companies have reached this "top threshold", leading the pack among small and medium-sized market value companies in terms of buyback intensity, with continuously highlighted market recognition. The confidence behind the strong buyback comes from the company's solid business implementation and innovative breakthroughs. Recently, YIDU TECH launched the MediCircle Clinical Evidence Intelligent System, accurately empowering clinical diagnosis and treatment and medical research, filling the gaps in clinical AI evidence-based decision-making. At the same time, actively entering the Hainan Boao Lecheng International Medical Tourism Pioneer Zone, deepening practical cooperation in medical AI, and helping to improve the quality of grassroots medical care, realizing the dual drive of "stabilizing expectations at the capital end and strengthening growth at the business end".